Loading clinical trials...
Loading clinical trials...
A Phase 4 Comparative Trial of Benzathine Penicillin G 2.4 Million Units Administered as a Single Dose Versus Three Successive Weekly Doses for Treatment of Early Syphilis in Subjects With or Without HIV Infection
Conditions
Interventions
Benzathine Penicillin
Locations
10
United States
University of Alabama at Birmingham School of Medicine - Infectious Disease
Birmingham, Alabama, United States
Emory University Hospital Midtown - Emory Clinic Infectious Diseases
Atlanta, Georgia, United States
Indiana University School of Medicine - Infectious Diseases
Indianapolis, Indiana, United States
Louisiana State University Health Sciences Center
New Orleans, Louisiana, United States
Johns Hopkins Bayview Medical Center - Infectious Diseases
Baltimore, Maryland, United States
Fenway Health - The Fenway Institute
Boston, Massachusetts, United States
Start Date
October 31, 2018
Primary Completion Date
September 7, 2022
Completion Date
March 20, 2023
Last Updated
January 14, 2025
NCT06716450
NCT06743204
NCT06829602
NCT06188442
NCT04958122
NCT05951751
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions